Locally delivered GLP-1 analogues liraglutide and exenatide enhance microvascular perfusion in individuals with and without type 2 diabetes.
Myo Myo AungKate SladeLeighton A R FreemanKatarina KosJacqueline L WhatmoreAngela C ShoreKunihiko AizawaPublished in: Diabetologia (2019)
This work was supported by Diabetes UK (grant numbers: 09/0003955 and 12/0004600 [RW and JM Collins Legacy, Funded Studentship]).